Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis

Lignende værker

• Efficacy of oral prolonged‐release mesalazine in moderately active ulcerative colitis
  af: Kristine Paridaens, et al.
  Udgivet: (2023-07-01)
• Optimised mesalazine therapy reduces ulcerative colitis recurrence across the mild-to-moderate disease spectrum: the IMPACT study
  af: Bolette Christophersen, et al.
  Udgivet: (2026-07-01)
• Role of 5-aminosalicylic acid in ulcerative colitis management in 8 Asian territories: a physician survey
  af: Julajak Limsrivilai, et al.
  Udgivet: (2025-04-01)
• Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
  af: Ajit Sood, et al.
  Udgivet: (2020-10-01)
• Effectiveness of treatment of moderate ulcerative colitis with prolonged mesalazine in real clinical practice
  af: O. V. Knyazev, et al.
  Udgivet: (2021-10-01)